Evidence map›Paper›PMID 28369789›Full record

ArticleClinical and experimental immunology2017

Increased interleukin (IL)-20 and IL-24 target osteoblasts and synovial monocytes in spondyloarthritis.

T W Kragstrup, M N Andersen, B Schiøttz-Christensen, A G Jurik, M Hvid, B Deleuran

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. IL-12/IL-23p40 identified as a downstream target of apremilast inTherapeutic advances in musculoskeletal disease · 2019
    Article
  18. IL-20 receptor cytokines in autoimmune diseases.Journal of leukocyte biology · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

T W KragstrupDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-6439-397X
M N AndersenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
B Schiøttz-ChristensenSpine Centre of Southern Denmark, Hospital Lillebaelt, Middelfart, Denmark.
A G JurikDepartment of Radiology, Aarhus University Hospital, Aarhus, Denmark.
M HvidDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
B DeleuranDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Aarhus University · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of spondyloarthritis (SpA) involves activation of the innate immune system, inflammation and new bone formation. The two cytokines interleukin (IL)-20 and IL-24 have been shown to link innate immune activation and tissue homeostasis. We hypothesized that these two cytokines are secreted as part of activation of the innate immune system and affect bone homeostasis in SpA. IL-20 and IL-24 were measured in plasma from axial SpA patients (n = 83). Peripheral SpA patients (n = 16) were included for in-vitro cell culture studies. The plasma IL-20 and IL-24 levels were increased in SpA patients compared with healthy controls (HCs) by 57 and 83%, respectively (both P < 0·0001). The Toll-like receptor 4-induced secretion of the two cytokines was greater in SpA peripheral blood mononuclear cells (PBMCs) compared with HC PBMCs. IL-20 and IL-24 increased the production of monocyte chemoattractant protein-1 by activated SpA synovial fluid monocytes, decreased the production of Dickkopf-1 by SpA fibroblast-like synovial cells and induced mineralization in human osteoblasts. Taken together, our findings indicate disease-aggravating functions of IL-20 and IL-24 in SpA.

Indexed as

AdultCalcification, PhysiologicChemokine CCL2FemaleHumansIntercellular Signaling Peptides and ProteinsInterleukin-24InterleukinsLeukocytes, MononuclearMaleMonocytesOsteoblastsSpondylarthritisSynovial FluidToll-Like Receptor 4CCL2 protein, humanChemokine CCL2DKK1 protein, humanIntercellular Signaling Peptides and Proteinsinterleukin 20Interleukin-24InterleukinsTLR4 protein, humanToll-Like Receptor 4interleukinmonocytespondylitisToll-like receptor

Identifiers

PMID28369789
PMCPMC5543495
OpenAlexW2789655418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.